With a key regulatory approval secured in Europe, Abbott Laboratories is joining the race to commercialize technology that ...

Abbott Laboratories (NYSE: ABT) stock was in fine health on the second-to-last trading day of the week, thanks to news from ...

Abbott Laboratories (NYSE:ABT) recently announced successful outcomes from its TRILUMINATE™ Pivotal trial for the TriClip™ system, showcasing significant improvements in patient outcomes for tricuspid ...

Abbott Laboratories closed 6.08% below its 52-week high of $141.23, which the company reached on March 4th.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

In a report released yesterday, Larry Biegelsen from Wells Fargo maintained a Buy rating on Abbott Laboratories (ABT – Research Report), with a ...

The company is first rolling out the use of the Volt system among European Union doctors who have already gained experience ...

AUSTIN, Texas (KAUZ) - Texas Governor Greg Abbott today signed a proclamation designating April as Sexual Assault Awareness ...

Johnson & Johnson and Boston Scientific have also recently made moves to sell their own coronary intravascular lithotripsy ...

Abbott (ABT) announced late-breaking data from its Triluminate Pivotal trial that show the TriClip transcatheter edge-to-edge repair system to ...

The company effectively received approval to sell an atrial fibrillation product in the European Union. There is an addressable market of 8 million people at present in that market, according to ...